Covista Inc. CVSA
123.00 USD -1.03 (-0.83%)
Nov 3, 2026, 3:21 PM EST
120.53 Day range 124.93
86.97 52-week range 142.13
- YTD
- +18.88%
- 1 year
- +28.66%
Analyst view
Consensus: buy
Buy
Price target (mean) 159.00 +29.3% upside
Now 123.00
- Target (low)
- 140.00
- Target (mean)
- 159.00
- Target (high)
- 175.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.22 | 2.18 – 2.29 | 2.43 | -8.5% | 514.34M | +2.2% | 3 |
| Next quarter | 2.54 | 2.48 – 2.60 | 1.98 | +28.4% | 531.63M | +9.2% | 4 |
| Current year | 9.13 | 9.10 – 9.20 | 8.25 | +10.6% | 2.08B | +6.6% | 4 |
| Next year | 10.06 | 9.90 – 10.27 | 9.13 | +10.3% | 2.23B | +7.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Sep 3, 2026 | Truist Securities | Downgrade | Buy | Hold |
| Jun 8, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| May 11, 2026 | Truist Securities | Maintained | Buy | Buy |
| Apr 17, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Mar 24, 2026 | Truist Securities | Initiated | — | Buy |
| Mar 2, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Jan 29, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 31, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 15, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Sep 23, 2025 | Barrington Research | Maintained | Outperform | Outperform |